Back
Seres Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
MCRB
Seres Therapeutics, Inc.
Last Price:
$15.10
Seasonality Move:
-13.23%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.
Seres Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.75 | Buy |
| 20-day SMA: | 15.31 | Buy |
| 50-day SMA: | 16.51 | Sell |
| 200-day SMA: | 14.2 | Buy |
| 8-day EMA: | 15.68 | Buy |
| 20-day EMA: | 15.72 | Buy |
| 50-day EMA: | 16.31 | Sell |
| 200-day EMA: | 16.09 | Sell |
Seres Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 50.87 | Buy |
| Chaikin Money Flow: | 37551 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Seres Therapeutics, Inc. Technical Analysis
| Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Seres Therapeutics, Inc. Stock
Is Seres Therapeutics, Inc. Stock a Buy?
-
Seres Therapeutics, Inc. share price is 15.96 while MCRB 8-day simple moving average is 15.75, which is a Buy signal.
-
The stock price of MCRB is 15.96 while Seres Therapeutics, Inc. 20-day SMA is 15.31, which makes it a Buy.
-
Seres Therapeutics, Inc. 50-day simple moving average is 16.51 while MCRB share price is 15.96, making it a Sell technically.
-
MCRB stock price is 15.96 and Seres Therapeutics, Inc. 200-day simple moving average is 14.20, creating a Buy signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
27
Seres Therapeutics, Inc. (MCRB)
is a Sell
Is Seres Therapeutics, Inc. a Buy or a Sell?
-
Seres Therapeutics, Inc. stock is rated a SellThe current Seres Therapeutics, Inc. [MCRB] share price is $15.96. The Score for MCRB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics, Inc. Stock Info
Market Cap:
139.7M
Price in USD:
15.96
Share Volume:
46K
Seres Therapeutics, Inc. 52-Week Range
52-Week High:
29.98
52-Week Low:
6.53
Sell
27
Seres Therapeutics, Inc. (MCRB)
is a Sell
Seres Therapeutics, Inc. Share Price Forecast
-
What is the Seres Therapeutics, Inc. stock price today?The Seres Therapeutics, Inc. stock price is 15.96 USD today.
-
Will MCRB stock go up or go down?Seres Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Seres Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics, Inc. is overvalued.
Is Seres Therapeutics, Inc. Stock a Buy?
-
Seres Therapeutics, Inc. share price is 15.96 while MCRB 8-day exponential moving average is 15.68, which is a Buy signal.
-
The stock price of MCRB is 15.96 while Seres Therapeutics, Inc. 20-day EMA is 15.72, which makes it a Buy.
-
Seres Therapeutics, Inc. 50-day exponential moving average is 16.31 while MCRB share price is 15.96, making it a Sell technically.
-
MCRB stock price is 15.96 and Seres Therapeutics, Inc. 200-day simple moving average is 16.09, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics, Inc.
Is Seres Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $4.48 per share, a decrease next quarter of $0.00 per share, a decrease this year of $11.20 per share, and a decrease next year of $1.03 per share.
Technical Analysis of Seres Therapeutics, Inc.
Should I short Seres Therapeutics, Inc. stock?
-
MCRB Moving Average Covergence Divergence (MACD) indicator is -0.22, suggesting Seres Therapeutics, Inc. is a Sell
-
Seres Therapeutics, Inc. Relative Strength Index (RSI) is 50.87, which suggest Seres Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Seres Therapeutics, Inc. is ( - ), which suggest Seres Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Seres Therapeutics, Inc. is ( - ), which suggest Seres Therapeutics, Inc. is a Buy
* Seres Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.